[Komentář ke článku HOPE-3: Statins Lower CV Events in Intermediate-CHD-Risk Patients]
{{output}}
The HOPE-3 study focused on identifying the significance of the polypill and mini-polypill in broad clinical practice, including individuals of different gender without cardiovascular diseases with an intermediate risk of cardiovascular diseases. The authors w... ...